Understanding the Mechanism of Action for Chimeric Antigen Receptor (CAR) Therapy

November 5, 2016

Learning Objectives

  • Describe the mechanism of action of CAR T cells and how they differ from other forms of cancer medicine.
  • Discuss the clinical logistics of autologous T cell therapy, including pheresis, processing, and replacement infusion.
  • Review steps needed to address the major treatment risks associated with CAR T cells, especially cytokine release syndrome.
  • Monitor patient response to treatment and proactively manage signs and symptoms of adverse effects.
  • Provide long-term supportive care for patients experiencing B-cell aplasia.
Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/05/2016
Course expires: 
04/30/2017
Event starts: 
11/05/2016 - 9:10am
Event ends: 
11/05/2016 - 10:10am
Cost:
$0.00
Rating: 
0
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.